Stock Quote
Auxilium Pharmaceuticals, Inc. (AUXL.O) (Nasdaq)
$34.74
2:12pm EST
-0.54%
$34.93
$35.23
155,624
$36.21
$34.58
$37.28
$17.96
1.03
293,579
AUXL.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Classon, Rolf | Chairman of the Board | -- |
| Anido, Armando | President, Chief Executive Officer, Director | 2,573,080 |
| Fickenscher, James | Chief Financial Officer | 995,338 |
Profile
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians. The Company’s product, Testim, is a topical 1% testosterone once-a-day gel indicated for the... Full Description
Company Address
Auxilium Pharmaceuticals, Inc.
40 Valley Stream Parkway
Malvern PA 19355
P: +1484.3215900
F: +1484.3215999
40 Valley Stream Parkway
Malvern PA 19355
P: +1484.3215900
F: +1484.3215999
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Solvay S.A. | €71.92 | +1.25 |
| Watson Pharmaceuticals, Inc. | $35.66 | +0.51 |
| Par Pharmaceutical Companies, Inc. | $23.99 | +0.54 |
| AUXL.O | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 10.92 | 29.90 |
| ROI(TTM) | -41.66 | 2.35 |
| ROE(TTM) | -64.17 | 3.59 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -0.21 |
| EPS Est. (Current Year) | -1.29 |
| Total Revenue | $42.14M |
| Net Income | $-14.95M |
| EPS | $-0.35 |
